Global Anti-Venom Market Research Report 2018

Publish Date
Electronic (PDF)

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
In 2017, the global Anti-Venom market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Anti-Venom market based on company, product type, application and key regions.

This report studies the global market size of Anti-Venom in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Venom in these regions.

This research report categorizes the global Anti-Venom market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Anti-Venom include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-Venom include

    Medtoxin Venom Laboratories

    Institute of Immunology

    Alomone Labs

    Sigma Aldrich

    Wyeth Pharmaceuticals

    Protherics PLC

    Bharat Serums and Vaccines

    Butantan Institute

    Haffkine Bio-Pharmaceutical Corporation

    Micropaharm Limited

Market Size Split by Type






Market Size Split by Application




Market size split by Region

    North America

        United States







        South Korea















    Central & South America


        Rest of Central & South America

    Middle East & Africa

        GCC Countries



        South Africa

The study objectives of this report are:

    To study and analyze the global Anti-Venom market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

    To understand the structure of Anti-Venom market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Anti-Venom manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the Anti-Venom with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of Anti-Venom submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-Venom are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Venom market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. 
Table of Contents
1 Study Coverage

    1.1 Anti-Venom Product

    1.2 Key Market Segments

    1.3 Key Manufacturers Covered

    1.4 Market by Type

        1.4.1 Global Anti-Venom Market Size Growth Rate by Type

        1.4.2 Cytotoxic

        1.4.3 Neurotoxic

        1.4.4 Haemotoxic

        1.4.5 Cardiotoxic

        1.4.6 Myotoxic

    1.5 Market by Application

        1.5.1 Global Anti-Venom Market Size Growth Rate by Application

        1.5.2 Snake

        1.5.3 Spider

        1.5.4 Scorpion

    1.6 Study Objectives

    1.7 Years Considered

2 Executive Summary

    2.1 Global Anti-Venom Market Size

        2.1.1 Global Anti-Venom Revenue 2016-2025

        2.1.2 Global Anti-Venom Sales 2016-2025

    2.2 Anti-Venom Growth Rate by Regions

        2.2.1 Global Anti-Venom Sales by Regions

        2.2.2 Global Anti-Venom Revenue by Regions

3 Breakdown Data by Manufacturers

    3.1 Anti-Venom Sales by Manufacturers

        3.1.1 Anti-Venom Sales by Manufacturers

        3.1.2 Anti-Venom Sales Market Share by Manufacturers

        3.1.3 Global Anti-Venom Market Concentration Ratio (CR5 and HHI)

    3.2 Anti-Venom Revenue by Manufacturers

        3.2.1 Anti-Venom Revenue by Manufacturers (2016-2018)

        3.2.2 Anti-Venom Revenue Share by Manufacturers (2016-2018)

    3.3 Anti-Venom Price by Manufacturers

    3.4 Anti-Venom Manufacturing Base Distribution, Product Types

        3.4.1 Anti-Venom Manufacturers Manufacturing Base Distribution, Headquarters

        3.4.2 Manufacturers Anti-Venom Product Category

        3.4.3 Date of International Manufacturers Enter into Anti-Venom Market

    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

    4.1 Global Anti-Venom Sales by Type

    4.2 Global Anti-Venom Revenue by Type

    4.3 Anti-Venom Price by Type

5 Breakdown Data by Application

    5.1 Overview

    5.2 Global Anti-Venom Breakdown Data by Application

6 North America

    6.1 North America Anti-Venom by Countries

        6.1.1 North America Anti-Venom Sales by Countries

        6.1.2 North America Anti-Venom Revenue by Countries

        6.1.3 United States

        6.1.4 Canada

        6.1.5 Mexico

    6.2 North America Anti-Venom by Type

    6.3 North America Anti-Venom by Application

    6.4 North America Anti-Venom by Company

7 Europe

    7.1 Europe Anti-Venom by Countries

        7.1.1 Europe Anti-Venom Sales by Countries

        7.1.2 Europe Anti-Venom Revenue by Countries

        7.1.3 Germany

        7.1.4 France

        7.1.5 UK

        7.1.6 Italy

        7.1.7 Russia

    7.2 Europe Anti-Venom by Type

    7.3 Europe Anti-Venom by Application

    7.4 Europe Anti-Venom by Company

8 Asia Pacific

    8.1 Asia Pacific Anti-Venom by Countries

        8.1.1 Asia Pacific Anti-Venom Sales by Countries

        8.1.2 Asia Pacific Anti-Venom Revenue by Countries

        8.1.3 China

        8.1.4 Japan

        8.1.5 Korea

        8.1.6 India

        8.1.7 Australia

        8.1.8 Indonesia

        8.1.9 Malaysia

        8.1.10 Philippines

        8.1.11 Thailand

        8.1.12 Vietnam

        8.1.13 Singapore

    8.2 Asia Pacific Anti-Venom by Type

    8.3 Asia Pacific Anti-Venom by Application

    8.4 Asia Pacific Anti-Venom by Company

9 Central & South America

    9.1 Central & South America Anti-Venom by Countries

        9.1.1 Central & South America Anti-Venom Sales by Countries

        9.1.2 Central & South America Anti-Venom Revenue by Countries

        9.1.3 Brazil

    9.2 Central & South America Anti-Venom by Type

    9.3 Central & South America Anti-Venom by Application

    9.4 Central & South America Anti-Venom by Company

10 Middle East and Africa

    10.1 Middle East and Africa Anti-Venom by Countries

        10.1.1 Middle East and Africa Anti-Venom Sales by Countries

        10.1.2 Middle East and Africa Anti-Venom Revenue by Countries

        10.1.3 GCC Countries

        10.1.4 Turkey

        10.1.5 Egypt

        10.1.6 South Africa

    10.2 Middle East and Africa Anti-Venom by Type

    10.3 Middle East and Africa Anti-Venom by Application

    10.4 Middle East and Africa Anti-Venom by Company

11 Company Profiles

    11.1 Medtoxin Venom Laboratories

        11.1.1 Medtoxin Venom Laboratories Company Details

        11.1.2 Company Description

        11.1.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.1.4 Anti-Venom Product Description

        11.1.5 Recent Development

    11.2 Institute of Immunology

        11.2.1 Institute of Immunology Company Details

        11.2.2 Company Description

        11.2.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.2.4 Anti-Venom Product Description

        11.2.5 Recent Development

    11.3 Alomone Labs

        11.3.1 Alomone Labs Company Details

        11.3.2 Company Description

        11.3.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.3.4 Anti-Venom Product Description

        11.3.5 Recent Development

    11.4 Sigma Aldrich

        11.4.1 Sigma Aldrich Company Details

        11.4.2 Company Description

        11.4.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.4.4 Anti-Venom Product Description

        11.4.5 Recent Development

    11.5 Wyeth Pharmaceuticals

        11.5.1 Wyeth Pharmaceuticals Company Details

        11.5.2 Company Description

        11.5.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.5.4 Anti-Venom Product Description

        11.5.5 Recent Development

    11.6 Protherics PLC

        11.6.1 Protherics PLC Company Details

        11.6.2 Company Description

        11.6.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.6.4 Anti-Venom Product Description

        11.6.5 Recent Development

    11.7 Bharat Serums and Vaccines

        11.7.1 Bharat Serums and Vaccines Company Details

        11.7.2 Company Description

        11.7.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.7.4 Anti-Venom Product Description

        11.7.5 Recent Development

    11.8 Butantan Institute

        11.8.1 Butantan Institute Company Details

        11.8.2 Company Description

        11.8.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.8.4 Anti-Venom Product Description

        11.8.5 Recent Development

    11.9 Haffkine Bio-Pharmaceutical Corporation

        11.9.1 Haffkine Bio-Pharmaceutical Corporation Company Details

        11.9.2 Company Description

        11.9.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.9.4 Anti-Venom Product Description

        11.9.5 Recent Development

    11.10 Micropaharm Limited

        11.10.1 Micropaharm Limited Company Details

        11.10.2 Company Description

        11.10.3 Sales, Revenue and Gross Margin of Anti-Venom

        11.10.4 Anti-Venom Product Description

        11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    12.1 Market Opportunities and Drivers

    12.2 Market Challenges

    12.3 Market Risks/Restraints

    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis

    13.1 Value Chain Analysis

        13.1.1 Typical Suppliers of Key Anti-Venom Raw Material

        13.1.2 Anti-Venom Customers

    13.2 Sales Channels Analysis

        13.2.1 Sales Channels Analysis

        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix

    15.1 Research Methodology

        15.1.1 Methodology/Research Approach

   Research Programs/Design

   Market Size Estimation

   Market Breakdown and Data Triangulation

        15.1.2 Data Source

   Secondary Sources

   Primary Sources

    15.2 Author Details

    15.3 Disclaimer